Abstract
Information on the organization and funding of medical research were obtained by a questionnaire from 10 member countries of the European Medical Research Councils. Responses show that the ratio of medical research expenditure to Gross Domestic Product varied from 0.1 to 0.2 per cent between these countries. In many countries, the largest single source of funds was pharmaceutical industry; its share of the total expenditure varied between one and 58 per cent. Excluding pharmaceutical industry, the contribution of Medical Research Councils (MRCs) varied from 2 to 22 per cent of the remaining expenditure. The present figures, derived directly from the national research organizations, were considerably higher than the respective OECD figures.
A great deal of variation between the national MRCs in the distribution of funds by field of research, type of activity, and type of cost was observed. The average cost of a research project varied between 4800–97000 U.S. dollars. The variation is probably explained to a great extent by availability of other sources of funds.
All MRCs used peer review in the assessment of research proposals. Criteria for peer review varied much. Only two MRCs mentioned specifically the needs of the society among the criteria. The various medical research organizations are described in detail in this report.
This is a preview of subscription content, access via your institution.
References
C. BURG, On the necessity of formulating a scientific policy concerning the foundations of science, in: E. HEIKKINEN, H. VUORI, T. LAAKSOVIRTA, P. ROSENQVIST, Eds,Research on Health Research, Proceedings of the European Symposium organized under the auspieces of the European Medical Research Councils, September 6–8, 1979, Academy of Finland, Helsinki, 1980, p. 13–31.
S. BLUME, Science policy research: its current state and future priorities, Norwegian Research Council for Science and the Humanities, Oslo, 1978.
C. DOLLERY, The end of the age of optimism: medical science in retrospect and prospect, Nuffield Provincial Hospitals Trust, London, 1978.
ESRC, Science Research Council priorities in: Europe, ESRC review No. 12, Stockholm, 1977.
K. FLEISCHHAUER, Federal Republic of Germany, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 89–102.
A. T. HANSEN, Denmark, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 49–58.
P. F. HJORT, H. SKOIE, Norway, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 153–168.
J. J. HOET, Belgium, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 11–28.
W. J. E. JESSOP, Ireland, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 121–130.
A. KAY,Research in Medicine: Problems and Prospects, Nuffield Provincial Hospitals Trust, London, 1977.
W. KRUSKAL, Taking data seriously, in: Y. ELKANA, J. LEDERBERG, R. K. MERTON, A. THACKRAY, H. ZUCKERMAN, Eds,Toward a metric of science: the advent of science indicators, Wiley, New York, 1978, p. 139–169.
S. LOCK, Peer review weighed in the balance,British Medical Journal, 285 (1982) 1224–1226.
Medical Research Council Handbook 1981–82, London, 1981.
Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973.
M. NIEMI, The institutionalization of health research, in: E. HEIKKINEN, H. VUORI, T. LAAKSOVIRTA, P. ROSENQVIST, Eds,Research on Health Research, Proceedings of the European Symposium organized under the auspieces of the European Medical Research Councils September 6–8, 1979, Academy of Finland, Helsinki, 1980, p. 148–154.
OECD, National accounts of OECD countries 1950–1979, vol. 1, Paris, 1981.
OECD, National accounts of OECD countries 1951–1980, vol. 1, Paris, 1982.
OECD, Science & technology indicators, basic statistical series, volume A, the objectives of government R&D funding, 1969–1981, DSTI/SPR/81.28, Paris, July 29, 1981.
A. QUERIDO, The Netherlands, In:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 143–152.
R. PREISIG, B. CUENI, Switzerland, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 223–252.
G. A. SMART, Britain, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 27–40.
A. TARKKANEN, Finland, in:Medical Research Systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 59–66.
L. WERKÖ, Sweden, in:Medical Research systems in Europe, Ciba Foundation Symposium 21 (new series), Elsevier, Amsterdam, 1973, p. 205–222.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poikolainen, K. Organization and funding of medical research in 10 European countries. Scientometrics 6, 327–358 (1984). https://doi.org/10.1007/BF02020131
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02020131
Keywords
- European Country
- Research Council
- Medical Research
- Pharmaceutical Industry
- Domestic Product